NCT07069595
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Clinical trial condition
Residual Disease
Explore clinical trials studying Residual Disease. Study availability and eligibility vary by location and protocol.
9 public trials
2 recruiting studies
Residual Disease trial results
NCT06134375
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +10 more
- Locations
-
- Indiana University Simon Cancer Center Indianapolis, Indiana, United States
- Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
- NYU Langone perimutter Cancer Center New York, United States
NCT04674306
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +11 more
- Locations
-
- Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT02389517
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
NCT06936345
- Conditions
- BPPV, Ear Diseases, Labyrinth Diseases, +9 more
- Locations
-
- Istanbul Medipol University Istanbul, Beykoz, Turkey (Türkiye)
NCT05117879
- Conditions
- Neoplasm, Residual, Neoplasms, Neoplastic Processes, +3 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan (roc), Taiwan
NCT03093207
- Conditions
- Aggressive Periodontitis, Mouth Diseases, Neoplasm, Residual, +8 more
- Locations
-
- College of Dentistry - São José dos Campos, Sao Paulo State University São José dos Campos, São Paulo, Brazil
Active, Not Recruiting
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients
NCT03945721
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +10 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
NCT03384914
- Conditions
- Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, +16 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory - Winship Cancer Institute Atlanta, Georgia, United States
- Indiana University - Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States